世界贸易组织的TRIPS豁免决定:太少太晚!

IF 1.6 Q2 LAW
Prabhash Ranjan, Praharsh Gour
{"title":"世界贸易组织的TRIPS豁免决定:太少太晚!","authors":"Prabhash Ranjan, Praharsh Gour","doi":"10.1017/S2044251322000571","DOIUrl":null,"url":null,"abstract":"Abstract The recently adopted Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver decision at the World Trade Organization is a grossly inadequate and insincere response to the COVID-19 pandemic. This paper criticizes the TRIPS waiver for being faulty on several fronts such as: excluding COVID-19 diagnostics and therapeutics from its fold and focusing only on COVID-19 vaccines; restricting its coverage to only patents and leaving out other intellectual property rights; excluding developed countries that possess manufacturing and technological capability from being eligible exporters of COVID-19 vaccines; and its perplexing silence on the transfer of technology. It will have negligible impact on fighting the pandemic, sets an enfeebled example for the future, and is a classic case of “too little too late”.","PeriodicalId":43342,"journal":{"name":"Asian Journal of International Law","volume":"13 1","pages":"10 - 21"},"PeriodicalIF":1.6000,"publicationDate":"2022-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The TRIPS Waiver Decision at the World Trade Organization: Too Little Too Late!\",\"authors\":\"Prabhash Ranjan, Praharsh Gour\",\"doi\":\"10.1017/S2044251322000571\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract The recently adopted Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver decision at the World Trade Organization is a grossly inadequate and insincere response to the COVID-19 pandemic. This paper criticizes the TRIPS waiver for being faulty on several fronts such as: excluding COVID-19 diagnostics and therapeutics from its fold and focusing only on COVID-19 vaccines; restricting its coverage to only patents and leaving out other intellectual property rights; excluding developed countries that possess manufacturing and technological capability from being eligible exporters of COVID-19 vaccines; and its perplexing silence on the transfer of technology. It will have negligible impact on fighting the pandemic, sets an enfeebled example for the future, and is a classic case of “too little too late”.\",\"PeriodicalId\":43342,\"journal\":{\"name\":\"Asian Journal of International Law\",\"volume\":\"13 1\",\"pages\":\"10 - 21\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2022-10-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of International Law\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/S2044251322000571\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of International Law","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/S2044251322000571","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"LAW","Score":null,"Total":0}
引用次数: 0

摘要

摘要世界贸易组织最近通过的与贸易有关的知识产权(TRIPS)豁免决定是对新冠肺炎疫情的严重不足和不真诚的应对。本文批评TRIPS豁免在几个方面存在缺陷,如:将新冠肺炎诊断和治疗排除在外,仅关注新冠肺炎疫苗;将其覆盖范围仅限于专利,而忽略了其他知识产权;将拥有制造和技术能力的发达国家排除在新冠肺炎疫苗的合格出口国之外;以及它对技术转让令人困惑的沉默。它对抗击疫情的影响微乎其微,为未来树立了一个软弱的榜样,是“太少太晚”的典型案例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The TRIPS Waiver Decision at the World Trade Organization: Too Little Too Late!
Abstract The recently adopted Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver decision at the World Trade Organization is a grossly inadequate and insincere response to the COVID-19 pandemic. This paper criticizes the TRIPS waiver for being faulty on several fronts such as: excluding COVID-19 diagnostics and therapeutics from its fold and focusing only on COVID-19 vaccines; restricting its coverage to only patents and leaving out other intellectual property rights; excluding developed countries that possess manufacturing and technological capability from being eligible exporters of COVID-19 vaccines; and its perplexing silence on the transfer of technology. It will have negligible impact on fighting the pandemic, sets an enfeebled example for the future, and is a classic case of “too little too late”.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.00
自引率
12.50%
发文量
58
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信